Viewing Study NCT06557421



Ignite Creation Date: 2024-10-25 @ 7:50 PM
Last Modification Date: 2024-10-26 @ 3:38 PM
Study NCT ID: NCT06557421
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-08-09

Brief Title: De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
Sponsor: None
Organization: None

Study Overview

Official Title: De-Escalation Study Evaluating Venetoclax and Azacitidine Discontinuation in AML Responding Patients
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: STOP VEN
Brief Summary: The goal of this clinical trial is to test efficacy and safety of a VENETOCLAX-AZACITIDINE VEN-AZA de-escalation strategy in Acute Myeloid Leukemia responding patients The main objectives of the study are

Evaluation of the efficacy of VEN-AZA de-escalation strategy by measuring the effect of VEN-AZA discontinuation in term of Disease-Free Survival
Evaluation of the other efficacy parameters and safety of VEN-AZA de-escalation strategy

Patients from the prospective study will be compared to a retrospective cohort of patients who will be selected on the basis of identical eligibility criteria

Participants will

Stop VEN-DASA treatment
Be closely monitored by regular evaluation of the disease
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None